
浏览全部资源
扫码关注微信
广东省中医院珠海医院乳腺科,珠海 519000
☒李东梅,副主任医师。E-mail:896184582@qq.com
收稿:2023-07-12,
网络首发:2024-03-02,
纸质出版:2024-05-12
移动端阅览
陈青青, 雷叶雁, 白爽, 等. 火龙罐防治乳腺癌化疗相关性恶心呕吐:随机对照试验[J]. 中国针灸, 2024,44(5):526-530.
CHEN Qingqing, LEI Yeyan, BAI Shuang, et al. Fire dragon cupping in prevention and treatment of chemotherapy-induced nausea and vomiting in breast cancer: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2024, 44(5): 526-530.
陈青青, 雷叶雁, 白爽, 等. 火龙罐防治乳腺癌化疗相关性恶心呕吐:随机对照试验[J]. 中国针灸, 2024,44(5):526-530. DOI: 10.13703/j.0255-2930.20230712-k0005.
CHEN Qingqing, LEI Yeyan, BAI Shuang, et al. Fire dragon cupping in prevention and treatment of chemotherapy-induced nausea and vomiting in breast cancer: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2024, 44(5): 526-530. DOI: 10.13703/j.0255-2930.20230712-k0005.
目的:
2
观察火龙罐防治乳腺癌化疗相关性恶心呕吐(CINV)的疗效及安全性。
方法:
2
将60例接受中高度致呕化疗方案的乳腺癌患者随机分为观察组(30例,脱落3例)和对照组(30例,脱落3例)。两组患者均在化疗当天及化疗后第1~3天给予盐酸托烷司琼5 mg静脉滴注,观察组在化疗后第1、3、5天行腹部火龙罐治疗。记录两组患者化疗后第1~6天恶心、呕吐、纳差、腹痛、腹胀发生情况,恶心、呕吐严重程度,恶心、呕吐、纳差持续天数,观察两组患者治疗前后焦虑自评量表(SAS)评分、舒适状况量表(GCQ)评分及补救止呕用药情况,并评估治疗安全性。
结果:
2
观察组患者化疗后第2~6天恶心、纳差、腹胀发生例数及恶心评分低于对照组(
P
<
0.05),化疗后第1~3天呕吐发生例数及呕吐评分低于对照组(
P
<
0.05),观察组患者恶心、呕吐、纳差持续天数短于对照组(
P
<
0.05)。观察组治疗后SAS评分、GCQ评分与治疗前比较差异无统计学意义(
P
>
0.05),对照组GCQ评分较治疗前降低(
P
<
0.05);治疗后两组间SAS评分、GCQ评分比较差异无统计学意义(
P
>
0.05)。两组患者补救用药例数比较差异无统计学意义(
P
>
0.05)。两组患者治疗过程中均无不良反应发生。
结论:
2
火龙罐治疗能有效降低乳腺癌化疗相关恶心、呕吐、纳差的发生率及恶心、呕吐程度,提高患者舒适度,且安全性较好。
Objective
2
To observe the clinical efficacy and safety of fire dragon cupping in prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in breast cancer.
Methods
2
Sixty breast cancer patients receiving medium-high emetogenic chemotherapy regimen were randomly divided into an observation group (30 cases
3 cases dropped out) and a control group (30 cases
3 cases dropped out). In both groups
5 mg tropisetron hydrochloride was given intravenously on the day of chemotherapy and 1st to 3rd days after chemotherapy. In the observation group
fire dragon cupping on the abdomen was applied on 1st
3rd and 5th days after chemotherapy. The incidence of nausea
vomiting
loss of appetite
abdominal pain
abdominal distension
the severity of nausea
vomiting on 1st to 6th days after chemotherapy
and the duration of nausea
vomiting
loss of appetite were observed in the two groups. The self-rating anxiety scale (SAS) score
general comfort questionnaire scale (GCQ) score before and after treatment and remedy antiemetic medication were observed in the two groups
and the safety was evaluated.
Results
2
On 2nd to 6th days after chemotherapy
the number of patients with nausea
loss of appetite and abdominal distension and nausea scores in the observation group were lower than those in the control group (
P
<
0.05). On 1st to 3rd days after chemotherapy
the number of patients with vomiting and vomiting scores in the observation group were lower than those in the control group (
P
<
0.05). The duration of nausea
vomiting and loss of appetite in the observation group were shorter than those in the control group (
P
<
0.05). In the observation group
there was no significant difference in SAS and GCQ scores before and after treatment (
P
>
0.05). After treatment
the GCQ score in the control group was decreased compared with that before treatment (
P
<
0.05). After treatment
there was no significant difference in SAS and GCQ scores between the two groups (
P
>
0.05).
There
was no significant difference in the number of patients using remedy medication between the two groups (
P
>
0.05).
No adverse reaction occurred during treatment in both groups.
Conclusion
2
Fire dragon cupping can effectively reduce the incidence of nausea
vomiting
loss of appetite and the severity of nausea
vomiting related to chemotherapy in breast cancer
and improve patient comfort
and have good safety.
0
浏览量
0
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621